THU0441 Potential Fatality Predictors Caused by Pneumocystis Pneumonia (PCP) in Rheumatic Disease
Identifieur interne : 000493 ( Main/Exploration ); précédent : 000492; suivant : 000494THU0441 Potential Fatality Predictors Caused by Pneumocystis Pneumonia (PCP) in Rheumatic Disease
Auteurs : R. Yanai [Japon] ; S. Isojima [Japon] ; H. Tsukamoto [Japon] ; T. Tokunaga [Japon] ; M. Umemura [Japon] ; H. Furuya [Japon] ; K. Otsuka [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; Y. Miwa [Japon] ; T. Kasama [Japon]Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2013-06.
Abstract
Background Complications of pneumocystis pneumonia (PCP) are one of the predictors of fatality in rheumatic disease. Although clinical characteristics and risk factors for PCP in rheumatic diseases have been studied, there have been no reports of poor prognosis factor of the PCP. Objectives We examined the poor prognosis factors caused by PCP in rheumatic disease at admission. Methods From 2010 to 2012, 28 patients with rheumatic diseases and coexisting PCP were examined retrospectively (rheumatoid arthritis, 19 patients; systemic lupus erythematosus, 2 patients; systemic sclerosis, 2 patients; microscopic polyangiitis, 2 patients; relapsing polychondritis, 1 patient; pseudogout, 1 patient; autoimmune hepatitis, 1 patient). We divided the patients into two groups: surviving patients (group A; n=23) and deceased patients (group B; n=5). Age, sex, smoking history, past history of pulmonary disease, hospitalization and prednisolone dosage were examined. The following were also recorded at admission: white blood cell count, lymphocyte count, arterial blood gas PaO2/FIO2 ratio, serum creatinine level with estimated glomerular filtration rate (eGFR), and the levels of hemoglobin, lactase dehydrogenase(LDH), albumin, C-reactive protein (CRP), β-D-glucan, Krebs von den Lungen-6 (KL-6), pulmonary surfactant-D (SP-D), IgG, and IgA. Results The results were as follows: Conclusions Either higher age, high serum creatinine levels and CRP or low serum albumin levels, IgA and PaO2/FIO2 ratio are potential fatality predictors following admission caused by PCP in patients with rheumatic disease. Disclosure of Interest None Declared
Url:
DOI: 10.1136/annrheumdis-2013-eular.969
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000A18
- to stream Istex, to step Curation: 000A18
- to stream Istex, to step Checkpoint: 000011
- to stream Main, to step Merge: 000492
- to stream Main, to step Curation: 000493
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">THU0441 Potential Fatality Predictors Caused by Pneumocystis Pneumonia (PCP) in Rheumatic Disease</title><author><name sortKey="Yanai, R" sort="Yanai, R" uniqKey="Yanai R" first="R." last="Yanai">R. Yanai</name></author><author><name sortKey="Isojima, S" sort="Isojima, S" uniqKey="Isojima S" first="S." last="Isojima">S. Isojima</name></author><author><name sortKey="Tsukamoto, H" sort="Tsukamoto, H" uniqKey="Tsukamoto H" first="H." last="Tsukamoto">H. Tsukamoto</name></author><author><name sortKey="Tokunaga, T" sort="Tokunaga, T" uniqKey="Tokunaga T" first="T." last="Tokunaga">T. Tokunaga</name></author><author><name sortKey="Umemura, M" sort="Umemura, M" uniqKey="Umemura M" first="M." last="Umemura">M. Umemura</name></author><author><name sortKey="Furuya, H" sort="Furuya, H" uniqKey="Furuya H" first="H." last="Furuya">H. Furuya</name></author><author><name sortKey="Otsuka, K" sort="Otsuka, K" uniqKey="Otsuka K" first="K." last="Otsuka">K. Otsuka</name></author><author><name sortKey="Takahashi, R" sort="Takahashi, R" uniqKey="Takahashi R" first="R." last="Takahashi">R. Takahashi</name></author><author><name sortKey="Wakabayashi, K" sort="Wakabayashi, K" uniqKey="Wakabayashi K" first="K." last="Wakabayashi">K. Wakabayashi</name></author><author><name sortKey="Yajima, N" sort="Yajima, N" uniqKey="Yajima N" first="N." last="Yajima">N. Yajima</name></author><author><name sortKey="Miwa, Y" sort="Miwa, Y" uniqKey="Miwa Y" first="Y." last="Miwa">Y. Miwa</name></author><author><name sortKey="Kasama, T" sort="Kasama, T" uniqKey="Kasama T" first="T." last="Kasama">T. Kasama</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:73705F50C867C1B225C5C8D6D7B59CF0394D146E</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1136/annrheumdis-2013-eular.969</idno><idno type="url">https://api.istex.fr/document/73705F50C867C1B225C5C8D6D7B59CF0394D146E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000A18</idno><idno type="wicri:Area/Istex/Curation">000A18</idno><idno type="wicri:Area/Istex/Checkpoint">000011</idno><idno type="wicri:doubleKey">0003-4967:2013:Yanai R:thu:potential:fatality</idno><idno type="wicri:Area/Main/Merge">000492</idno><idno type="wicri:Area/Main/Curation">000493</idno><idno type="wicri:Area/Main/Exploration">000493</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">THU0441 Potential Fatality Predictors Caused by Pneumocystis Pneumonia (PCP) in Rheumatic Disease</title><author><name sortKey="Yanai, R" sort="Yanai, R" uniqKey="Yanai R" first="R." last="Yanai">R. Yanai</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Isojima, S" sort="Isojima, S" uniqKey="Isojima S" first="S." last="Isojima">S. Isojima</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Tsukamoto, H" sort="Tsukamoto, H" uniqKey="Tsukamoto H" first="H." last="Tsukamoto">H. Tsukamoto</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Tokunaga, T" sort="Tokunaga, T" uniqKey="Tokunaga T" first="T." last="Tokunaga">T. Tokunaga</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Umemura, M" sort="Umemura, M" uniqKey="Umemura M" first="M." last="Umemura">M. Umemura</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Furuya, H" sort="Furuya, H" uniqKey="Furuya H" first="H." last="Furuya">H. Furuya</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Otsuka, K" sort="Otsuka, K" uniqKey="Otsuka K" first="K." last="Otsuka">K. Otsuka</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Takahashi, R" sort="Takahashi, R" uniqKey="Takahashi R" first="R." last="Takahashi">R. Takahashi</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Wakabayashi, K" sort="Wakabayashi, K" uniqKey="Wakabayashi K" first="K." last="Wakabayashi">K. Wakabayashi</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Yajima, N" sort="Yajima, N" uniqKey="Yajima N" first="N." last="Yajima">N. Yajima</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Miwa, Y" sort="Miwa, Y" uniqKey="Miwa Y" first="Y." last="Miwa">Y. Miwa</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author><author><name sortKey="Kasama, T" sort="Kasama, T" uniqKey="Kasama T" first="T." last="Kasama">T. Kasama</name><affiliation wicri:level="3"><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Showa University, School Of Medicine, Tokyo</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of the Rheumatic Diseases</title><title level="j" type="abbrev">Ann Rheum Dis</title><idno type="ISSN">0003-4967</idno><idno type="eISSN">1468-2060</idno><imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><date type="published" when="2013-06">2013-06</date><biblScope unit="volume">72</biblScope><biblScope unit="issue">Suppl 3</biblScope><biblScope unit="page" from="A313">A313</biblScope></imprint><idno type="ISSN">0003-4967</idno></series><idno type="istex">73705F50C867C1B225C5C8D6D7B59CF0394D146E</idno><idno type="DOI">10.1136/annrheumdis-2013-eular.969</idno><idno type="href">annrheumdis-72-A313-3.pdf</idno><idno type="ArticleID">annrheumdis-2013-eular.969</idno><idno type="local">annrheumdis;72/Suppl_3/A313-c</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0003-4967</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background Complications of pneumocystis pneumonia (PCP) are one of the predictors of fatality in rheumatic disease. Although clinical characteristics and risk factors for PCP in rheumatic diseases have been studied, there have been no reports of poor prognosis factor of the PCP. Objectives We examined the poor prognosis factors caused by PCP in rheumatic disease at admission. Methods From 2010 to 2012, 28 patients with rheumatic diseases and coexisting PCP were examined retrospectively (rheumatoid arthritis, 19 patients; systemic lupus erythematosus, 2 patients; systemic sclerosis, 2 patients; microscopic polyangiitis, 2 patients; relapsing polychondritis, 1 patient; pseudogout, 1 patient; autoimmune hepatitis, 1 patient). We divided the patients into two groups: surviving patients (group A; n=23) and deceased patients (group B; n=5). Age, sex, smoking history, past history of pulmonary disease, hospitalization and prednisolone dosage were examined. The following were also recorded at admission: white blood cell count, lymphocyte count, arterial blood gas PaO2/FIO2 ratio, serum creatinine level with estimated glomerular filtration rate (eGFR), and the levels of hemoglobin, lactase dehydrogenase(LDH), albumin, C-reactive protein (CRP), β-D-glucan, Krebs von den Lungen-6 (KL-6), pulmonary surfactant-D (SP-D), IgG, and IgA. Results The results were as follows: Conclusions Either higher age, high serum creatinine levels and CRP or low serum albumin levels, IgA and PaO2/FIO2 ratio are potential fatality predictors following admission caused by PCP in patients with rheumatic disease. Disclosure of Interest None Declared</div></front></TEI><affiliations><list><country><li>Japon</li></country><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><noRegion><name sortKey="Yanai, R" sort="Yanai, R" uniqKey="Yanai R" first="R." last="Yanai">R. Yanai</name></noRegion><name sortKey="Furuya, H" sort="Furuya, H" uniqKey="Furuya H" first="H." last="Furuya">H. Furuya</name><name sortKey="Isojima, S" sort="Isojima, S" uniqKey="Isojima S" first="S." last="Isojima">S. Isojima</name><name sortKey="Kasama, T" sort="Kasama, T" uniqKey="Kasama T" first="T." last="Kasama">T. Kasama</name><name sortKey="Miwa, Y" sort="Miwa, Y" uniqKey="Miwa Y" first="Y." last="Miwa">Y. Miwa</name><name sortKey="Otsuka, K" sort="Otsuka, K" uniqKey="Otsuka K" first="K." last="Otsuka">K. Otsuka</name><name sortKey="Takahashi, R" sort="Takahashi, R" uniqKey="Takahashi R" first="R." last="Takahashi">R. Takahashi</name><name sortKey="Tokunaga, T" sort="Tokunaga, T" uniqKey="Tokunaga T" first="T." last="Tokunaga">T. Tokunaga</name><name sortKey="Tsukamoto, H" sort="Tsukamoto, H" uniqKey="Tsukamoto H" first="H." last="Tsukamoto">H. Tsukamoto</name><name sortKey="Umemura, M" sort="Umemura, M" uniqKey="Umemura M" first="M." last="Umemura">M. Umemura</name><name sortKey="Wakabayashi, K" sort="Wakabayashi, K" uniqKey="Wakabayashi K" first="K." last="Wakabayashi">K. Wakabayashi</name><name sortKey="Yajima, N" sort="Yajima, N" uniqKey="Yajima N" first="N." last="Yajima">N. Yajima</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000493 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000493 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:73705F50C867C1B225C5C8D6D7B59CF0394D146E
|texte= THU0441 Potential Fatality Predictors Caused by Pneumocystis Pneumonia (PCP) in Rheumatic Disease
}}
| This area was generated with Dilib version V0.6.25. |  |